Document 0367 DOCN M9490367 TI Kinetics and mechanism of autoprocessing of human immunodeficiency virus type 1 protease from an analog of the Gag-Pol polyprotein. DT 9411 AU Louis JM; Nashed NT; Parris KD; Kimmel AR; Jerina DM; Laboratory of Cellular and Developmental Biology, National; Institute of Diabetes and Digestive and Kidney Diseases, National; Institutes of Health, Bethesda, MD 20892. SO Proc Natl Acad Sci U S A. 1994 Aug 16;91(17):7970-4. Unique Identifier : AIDSLINE MED/94336669 AB Upon renaturation, the polyprotein MBP-delta TF-Protease-delta Pol, consisting of HIV-1 protease and short native sequences from the trans-frame protein (delta TF) and the polymerase (delta Pol) fused to the maltose-binding protein (MBP) of Escherichia coli, undergoes autoprocessing to produce the mature protease in two steps. The initial step corresponds to cleavage of the N-terminal sequence to release the protein intermediate Protease-delta Pol, which has enzymatic activity comparable to that of the mature enzyme. Subsequently, the mature enzyme is formed by a slower cleavage at the C terminus. The rate of increase in enzymatic activity is identical to that of the appearance of MBP-delta TF and the disappearance of the MBP-delta TF-Protease-delta Pol. Initial rates are linearly dependent on the protein concentration, indicating that the N-terminal cleavage is first-order in protein concentration. The reaction is competitively inhibited by pepstatin A and has a pH rate profile similar to that of the mature enzyme. These results and molecular modeling studies are discussed in terms of a mechanism in which a dimeric full-length fusion protein must form prior to rate-limiting intramolecular cleavage of the N-terminal sequence that leads to an increase in enzymatic activity. DE Amino Acid Sequence Carrier Proteins/BIOSYNTHESIS Escherichia coli/METABOLISM Fusion Proteins, gag-pol/*METABOLISM Hydrogen-Ion Concentration HIV Protease/*BIOSYNTHESIS/CHEMISTRY/METABOLISM HIV-1/*ENZYMOLOGY Kinetics Models, Molecular Molecular Sequence Data Oligopeptides/METABOLISM Pepstatins/PHARMACOLOGY Protein Folding Protein Structure, Secondary Substrate Specificity JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).